Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis?

Journal of Rheumatology

Volumn 33, Issue 10, 2006, Pages 1934-1935

  Fisher, Benjamin A C ^a,b   Keat, Andrew ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TECHNETIUM 99M; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

DRUG ABSORPTION; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG UPTAKE; DRUG USE; EDITORIAL; HUMAN; INFLAMMATORY MONOARTHRITIS; MONARTHRITIS; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SCINTIGRAPHY; SPONDYLOARTHROPATHY; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, INTRA-ARTICULAR; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750002886     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Nestorov I. Clinical pharmacokinetics of TNF antagonists: how do they differ? Semin Arthritis Rheum 2005;34 Suppl 1:12-8.
2. Bird HA, Ring EF, Daniel R, Bacon PA. Comparison of intraarticular methotrexate with intra-articular triamcinolone hexacetonide by thermography. Curr Med Res Opin 1977;5:141-6.
3. Armstrong RD, English J, Gibson T, Chakraborty J, Marks V. Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann Rheum Dis 1981;40:571-4.
4. Dreher R, Flaig W, Leitzeke D. Treatment of rheumatoid arthritis by intra-articular injections with TNFα blockers [abstract]. Arthritis Rheum 2001;44 Suppl:S42.
5. Andonopoulos AP, Meimaris N, Daoussis D, Bounas A, Yiannopoulos G. Intraarticular anti-tumor necrosis factor α antibody in recalcitrant Behcet's disease [abstract]. Clin Exp Rheumatol 2003;21 Suppl 30:557-8.
6. Bokarewa M, Tarkowski A. Local infusion of infliximab for the treatment of acute joint inflammation. Ann Rheum Dis 2003; 62:783-4.
7. Nikas SN, Temekonidis TI, Zikou AK, Argyropoulou MI, Efremidis S, Drosos AA. Treatment of resistant rheumatoid arthritis by intraarticular infliximab injections: a pilot study. Ann Rheum Dis 2004;63:102-3.
8. Schatteman L, Gyselbrecht L, De Clercq L, Mielants H. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab. J Rheumatol 2006;33:82-5.
9. Taylor PC. Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy. Rheumatology Oxford 2005;44:721-8.
10. Chatzigiannis I, Kakavouli G, Sakellariou G, Vezyridis C, Voudouris K. Intra-articular injection of infliximab in resistant inflamed joints of rheumatoid arthritis and spondyloarthropathies [abstract]. Ann Rheum Dis 2004;63 Suppl:418.
11. Conti F, Priori R, Chimenti MS, et al. Successful treatment with intraarticular infliximab for resistant knee monoarthritis in a patient with spondyloarthropathy. Arthritis Rheum 2005;52:1224-6.
12. Osborn TG. Intraarticular etanercept versus saline in rheumatoid arthritis: a single injection double-blind placebo controlled study [abstract]. Arthritis Rheum 2002;46 Suppl:S518.
13. Bliddal H, Qvistgaard E, Terslev L, et al. Injection of etanercept into arthritis joints: dose-response and efficacy [abstract]. Arthritis Rheum 2002;46 Suppl:S518.
14. Hobbs K. Chronic sarcoid arthritis treated with intraarticular etanercept. Arthritis Rheum 2005;52:987-8.
15. Arnold EL, Khanna D, Paulus H, Goodman MP. Acute injection site reaction to intraarticular etanercept administration. Arthritis Rheum 2003;48:2078-9.